{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:37:06Z","timestamp":1792103826316,"version":"4.4.0"},"reference-count":70,"publisher":"Portland Press Ltd.","issue":"12","license":[{"start":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T00:00:00Z","timestamp":1639699200000},"content-version":"vor","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,12,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Among chronic liver diseases, fatty liver has the highest incidence worldwide. Coexistence of fatty liver and other chronic diseases, such as diabetes, hepatitis B virus (HBV) and Helicobacter pylori (Hp) infection, is common in clinical practice. The present study was conducted to analyze the prevalence and association of coexisting diseases in patients with fatty liver and to investigate how coexisting diseases contribute to abnormal transaminase and lipid profiles. We enrolled participants who were diagnosed with fatty liver via ultrasound in the physical examination center of West China Hospital. Multivariable logistic regression was used to determine the adjusted odds ratios (ORs). We found that 23.6% of patients who underwent physical examinations were diagnosed with fatty liver. These patients had higher risks of metabolic syndrome (MetS), type 2 diabetes mellitus (T2DM), and hypertension and a lower risk of HBV infection. The risks of Hp infection and hyperthyroidism did not statistically differ. When fatty liver coexisted with T2DM, MetS and thyroid dysfunction, it conferred a higher risk of elevated transaminase. Fatty liver was positively correlated with triglycerides, cholesterol and low-density lipoprotein cholesterol (LDL-C) and negatively correlated with HBV; thus, HBV had a neutralizing effect on lipid metabolism when coexisting with fatty liver. In conclusion, patients with fatty liver that coexists with T2DM, MetS and thyroid dysfunction are more prone to elevated transaminase levels. Patients with both fatty liver and HBV may experience a neutralizing effect on their lipid metabolism. Thus, lipid alterations should be monitored in these patients during antiviral treatment for HBV.<\/jats:p>","DOI":"10.1042\/bsr20211769","type":"journal-article","created":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T11:11:34Z","timestamp":1639739494000},"update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Abnormal transaminase and lipid profiles in coexisting diseases in patients with fatty liver: a population study in Sichuan"],"prefix":"10.1042","volume":"41","author":[{"given":"Wei","family":"Jiang","sequence":"first","affiliation":[{"name":"Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China"},{"name":"Division of Infectious Diseases, State Key Laboratory of Biotherapy and Center of Infectious Disease, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-hai","family":"Liu","sequence":"additional","affiliation":[{"name":"Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China"},{"name":"Division of Infectious Diseases, State Key Laboratory of Biotherapy and Center of Infectious Disease, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongbo","family":"Wu","sequence":"additional","affiliation":[{"name":"Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China"},{"name":"Division of Infectious Diseases, State Key Laboratory of Biotherapy and Center of Infectious Disease, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Juan","family":"Wang","sequence":"additional","affiliation":[{"name":"Health Management Center, West China Hospital of Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3912-2067","authenticated-orcid":false,"given":"Hong","family":"Tang","sequence":"additional","affiliation":[{"name":"Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China"},{"name":"Division of Infectious Diseases, State Key Laboratory of Biotherapy and Center of Infectious Disease, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2021,12,17]]},"reference":[{"key":"2021121711112148600_B1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2021121711112148600_B2","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","article-title":"Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"5","author":"Ye","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"2021121711112148600_B3","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1002\/hep.31150","article-title":"Epidemiological features of NAFLD from 1999 to 2018 in China","volume":"71","author":"Zhou","year":"2020","journal-title":"Hepatology"},{"key":"2021121711112148600_B4","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.jhep.2017.06.003","article-title":"New trends on obesity and NAFLD in Asia","volume":"67","author":"Fan","year":"2017","journal-title":"J. Hepatol."},{"key":"2021121711112148600_B5","doi-asserted-by":"publisher","first-page":"154170","DOI":"10.1016\/j.metabol.2020.154170","article-title":"Complications, morbidity and mortality of nonalcoholic fatty liver disease","volume":"111s","author":"Mantovani","year":"2020","journal-title":"Metabolism."},{"key":"2021121711112148600_B6","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2021121711112148600_B7","doi-asserted-by":"publisher","first-page":"372","DOI":"10.2337\/dc17-1902","article-title":"Nonalcoholic fatty liver disease and risk of incident type 2 diabetes: a meta-analysis","volume":"41","author":"Mantovani","year":"2018","journal-title":"Diabetes Care"},{"key":"2021121711112148600_B8","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41575-020-0316-6","article-title":"From NAFLD to MAFLD: when pathophysiology succeeds","volume":"17","author":"Tilg","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2021121711112148600_B9","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1056\/NEJMcp1001110","article-title":"Clinical practice. Helicobacter pylori infection","volume":"362","author":"McColl","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"2021121711112148600_B10","doi-asserted-by":"publisher","first-page":"28891133","DOI":"10.1111\/hel.12411","article-title":"Helicobacter pylori infection and extragastric diseases in 2017","volume":"22","author":"de Korwin","year":"2017","journal-title":"Helicobacter"},{"key":"2021121711112148600_B11","doi-asserted-by":"publisher","first-page":"743","DOI":"10.3389\/fmicb.2017.00743","article-title":"The possible role of Helicobacter pylori infection in non-alcoholic fatty liver disease","volume":"8","author":"Cheng","year":"2017","journal-title":"Front. Microbiol."},{"key":"2021121711112148600_B12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.metabol.2012.06.007","article-title":"Helicobacter pylori infection in patients with nonalcoholic fatty liver disease","volume":"62","author":"Polyzos","year":"2013","journal-title":"Metabolism"},{"key":"2021121711112148600_B13","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s00535-017-1337-y","article-title":"A cohort study on Helicobacter pylori infection associated with nonalcoholic fatty liver disease","volume":"52","author":"Kim","year":"2017","journal-title":"J. Gastroenterol."},{"key":"2021121711112148600_B14","doi-asserted-by":"publisher","first-page":"e0202325","DOI":"10.1371\/journal.pone.0202325","article-title":"Association between cagA negative Helicobacter pylori status and nonalcoholic fatty liver disease among adults in the United States","volume":"13","author":"Kang","year":"2018","journal-title":"PLoS One"},{"key":"2021121711112148600_B15","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.metabol.2019.04.012","article-title":"Association between Helicobacter pylori infection and risk of nonalcoholic fatty liver disease: an updated meta-analysis","volume":"96","author":"Mantovani","year":"2019","journal-title":"Metabolism"},{"key":"2021121711112148600_B16","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrendo.2018.10","article-title":"Direct effects of thyroid hormones on hepatic lipid metabolism","volume":"14","author":"Sinha","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"2021121711112148600_B17","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1159\/000492324","article-title":"Association between thyroid-stimulating hormone levels and non-alcoholic fatty liver disease is not independent from metabolic syndrome criteria","volume":"7","author":"Janovsky","year":"2018","journal-title":"Eur. Thyroid J."},{"key":"2021121711112148600_B18","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.dld.2018.08.012","article-title":"Association of non-alcoholic fatty liver disease with thyroid function: A systematic review and meta-analysis","volume":"50","author":"Guo","year":"2018","journal-title":"Digest. Liver Dis."},{"key":"2021121711112148600_B19","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1159\/000454920","article-title":"Nonalcoholic fatty liver disease is not associated with thyroid hormone levels and hypothyroidism: a systematic review and meta-analysis","volume":"6","author":"Jaruvongvanich","year":"2017","journal-title":"Eur. Thyroid J."},{"key":"2021121711112148600_B20","doi-asserted-by":"publisher","first-page":"8102","DOI":"10.3748\/wjg.v20.i25.8102","article-title":"Non-alcoholic fatty liver disease and thyroid dysfunction: a systematic review","volume":"20","author":"Eshraghian","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"2021121711112148600_B21","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1002\/hep.31204","article-title":"Thyroid hormones and thyromimetics: a new approach to NASH?","volume":"72","author":"Sinha","year":"2020","journal-title":"Hepatology"},{"key":"2021121711112148600_B22","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1016\/S0140-6736(19)32731-X","article-title":"Improving NASH with a little help from thyromimetics","volume":"394","author":"Ratziu","year":"2019","journal-title":"Lancet"},{"key":"2021121711112148600_B23","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/nrendo.2016.103","article-title":"Thyroid function: poor thyroid function linked to NAFLD","volume":"12","author":"Geach","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"key":"2021121711112148600_B24","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S2468-1253(18)30056-6","article-title":"Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study","volume":"3","year":"2018","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"2021121711112148600_B25","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/hep.30857","article-title":"Nonalcoholic steatohepatitis is associated with liver-related outcomes and all-cause mortality in chronic Hepatitis B","volume":"71","author":"Choi","year":"2020","journal-title":"Hepatology"},{"key":"2021121711112148600_B26","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.1007\/s10620-015-3772-z","article-title":"Interactions of Hepatitis B virus infection with nonalcoholic fatty liver disease: possible mechanisms and clinical impact","volume":"60","author":"Lin","year":"2015","journal-title":"Dig. Dis. Sci."},{"key":"2021121711112148600_B27","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.jhep.2014.05.045","article-title":"Prevalence and causes of elevated serum aminotransferase levels in a population-based cohort of persons with chronic hepatitis B virus infection","volume":"61","author":"Spradling","year":"2014","journal-title":"J. Hepatol."},{"key":"2021121711112148600_B28","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","author":"WHO Expert Consultation","year":"2004","journal-title":"Lancet"},{"key":"2021121711112148600_B29","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1053\/gast.2002.35354","article-title":"The utility of radiological imaging in nonalcoholic fatty liver disease","volume":"123","author":"Saadeh","year":"2002","journal-title":"Gastroenterology"},{"key":"2021121711112148600_B30","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"J. Hepatol."},{"key":"2021121711112148600_B31","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","article-title":"Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"2021121711112148600_B32","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.2337\/dc14-S005","article-title":"Executive summary: standards of medical care in diabetes\u20132014","volume":"37","year":"2014","journal-title":"Diabetes Care"},{"key":"2021121711112148600_B33","first-page":"91","article-title":"Microdose 14C-urea breath test in detection of Helicobacter pylori","volume":"47","author":"Biela\u0144ski","year":"1996","journal-title":"J. Physiol. Pharmacol."},{"key":"2021121711112148600_B34","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/S0140-6736(11)60276-6","article-title":"Subclinical thyroid disease","volume":"379","author":"Cooper","year":"2012","journal-title":"Lancet"},{"key":"2021121711112148600_B35","doi-asserted-by":"publisher","first-page":"e0177713","DOI":"10.1371\/journal.pone.0177713","article-title":"Serum HBV surface antigen positivity is associated with low prevalence of metabolic syndrome: a meta-analysis","volume":"12","author":"Li","year":"2017","journal-title":"PLoS ONE"},{"key":"2021121711112148600_B36","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/apt.15575","article-title":"Systematic review: chronic viral hepatitis and metabolic derangement","volume":"51","author":"Wang","year":"2020","journal-title":"Aliment. Pharmacol. Ther."},{"key":"2021121711112148600_B37","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1111\/j.1440-1746.2010.06300.x","article-title":"Lower prevalence of hypercholesterolemia and hyperglyceridemia found in subjects with seropositivity for both hepatitis B and C strains independently","volume":"25","author":"Chen","year":"2010","journal-title":"J. Gastroenterol. Hepatol."},{"key":"2021121711112148600_B38","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1053\/j.gastro.2007.03.039","article-title":"Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARgamma","volume":"132","author":"Kim","year":"2007","journal-title":"Gastroenterology"},{"key":"2021121711112148600_B39","doi-asserted-by":"publisher","first-page":"7213","DOI":"10.3748\/wjg.v20.i23.7213","article-title":"Association between metabolic factors and chronic hepatitis B virus infection","volume":"20","author":"Chiang","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"2021121711112148600_B40","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/ajg.2009.560","article-title":"Interaction of adipokines and hepatitis B virus on histological liver injury in the Chinese","volume":"105","author":"Wong","year":"2010","journal-title":"Am. J. Gastroenterol."},{"key":"2021121711112148600_B41","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1038\/oby.2011.32","article-title":"Relations of circulating resistin and adiponectin and cardiac structure and function: the Framingham Offspring Study","volume":"20","author":"McManus","year":"2012","journal-title":"Obesity (Silver Spring)"},{"key":"2021121711112148600_B42","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1099\/jgv.0.000813","article-title":"Hepatitis B virus prevents excessive viral production via reduction of cell death-inducing DFF45-like effectors","volume":"98","author":"Yasumoto","year":"2017","journal-title":"J. Gen. Virol."},{"key":"2021121711112148600_B43","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12944-018-0683-y","article-title":"Serum lipids as an indicator for the alteration of liver function in patients with hepatitis B","volume":"17","author":"Arain","year":"2018","journal-title":"Lipids Health Dis."},{"key":"2021121711112148600_B44","doi-asserted-by":"publisher","first-page":"e0156166","DOI":"10.1371\/journal.pone.0156166","article-title":"Covariation analysis of serumal and urinary metabolites suggests aberrant glycine and fatty acid metabolism in chronic hepatitis B","volume":"11","author":"Yang","year":"2016","journal-title":"PLoS ONE"},{"key":"2021121711112148600_B45","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.metabol.2018.01.007","article-title":"A broad investigation of the HBV-mediated changes to primary hepatocyte physiology reveals HBV significantly alters metabolic pathways","volume":"83","author":"Lamontagne","year":"2018","journal-title":"Metabolism"},{"key":"2021121711112148600_B46","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1042\/BJ20081336","article-title":"Hepatitis B virus X protein induces lipogenic transcription factor SREBP1 and fatty acid synthase through the activation of nuclear receptor LXRalpha","volume":"416","author":"Kim","year":"2008","journal-title":"Biochem. J."},{"key":"2021121711112148600_B47","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/nrd4280","article-title":"Liver X receptors in lipid metabolism: opportunities for drug discovery","volume":"13","author":"Hong","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"2021121711112148600_B48","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jhep.2012.02.027","article-title":"Non-alcoholic fatty liver disease across the spectrum of hypothyroidism","volume":"57","author":"Chung","year":"2012","journal-title":"J. Hepatol."},{"key":"2021121711112148600_B49","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1007\/s10620-011-2006-2","article-title":"Prevalence of hypothyroidism in nonalcoholic fatty liver disease","volume":"57","author":"Pagadala","year":"2012","journal-title":"Dig. Dis. Sci."},{"key":"2021121711112148600_B50","first-page":"584","article-title":"Nonalcoholic fatty liver disease in a cluster of Iranian population: thyroid status and metabolic risk factors","volume":"16","author":"Eshraghian","year":"2013","journal-title":"Arch. Iran. Med."},{"key":"2021121711112148600_B51","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1089\/thy.2011.0279","article-title":"Inverse association between serum free thyroxine levels and hepatic steatosis: results from the Study of Health in Pomerania","volume":"22","author":"Ittermann","year":"2012","journal-title":"Thyroid"},{"key":"2021121711112148600_B52","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1590\/S0004-28032011000300006","article-title":"Gluco-lipidic indices in treated hypothyroidism associated with nonalcoholic fatty liver disease","volume":"48","author":"Mazo","year":"2011","journal-title":"Arq. Gastroenterol."},{"key":"2021121711112148600_B53","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1007\/s10620-005-3012-z","article-title":"The effect of Helicobacter pylori on insulin resistance","volume":"50","author":"Aydemir","year":"2005","journal-title":"Dig. Dis. Sci."},{"key":"2021121711112148600_B54","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/j.1523-5378.2009.00705.x","article-title":"Helicobacter pylori infection significantly increases insulin resistance in the asymptomatic Japanese population","volume":"14","author":"Gunji","year":"2009","journal-title":"Helicobacter"},{"key":"2021121711112148600_B55","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/hep.26672","article-title":"Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes","volume":"59","author":"Birkenfeld","year":"2014","journal-title":"Hepatology"},{"key":"2021121711112148600_B56","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1080\/21505594.2015.1043505","article-title":"Helicobacter pylori neutrophil-activating protein induces release of histamine and interleukin-6 through G protein-mediated MAPKs and PI3K\/Akt pathways in HMC-1 cells","volume":"6","author":"Tsai","year":"2015","journal-title":"Virulence"},{"key":"2021121711112148600_B57","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/hel.12302","article-title":"Increased exhaled 8-isoprostane and interleukin-6 in patients with Helicobacter pylori infection","volume":"21","author":"Yildirim","year":"2016","journal-title":"Helicobacter"},{"key":"2021121711112148600_B58","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1126\/science.271.5249.665","article-title":"IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance","volume":"271","author":"Hotamisligil","year":"1996","journal-title":"Science"},{"key":"2021121711112148600_B59","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.it.2003.10.013","article-title":"Inflammation: the link between insulin resistance, obesity and diabetes","volume":"25","author":"Dandona","year":"2004","journal-title":"Trends Immunol."},{"key":"2021121711112148600_B60","first-page":"158","article-title":"Association between Helicobacter pylori and serum Leptin in Iranian dyspeptic patients","volume":"5","author":"Hemmasi","year":"2013","journal-title":"Middle East J. Digest. Dis."},{"key":"2021121711112148600_B61","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1210\/en.2008-1271","article-title":"Leptin augments the acute suppressive effects of insulin on hepatic very low-density lipoprotein production in rats","volume":"150","author":"Huang","year":"2009","journal-title":"Endocrinology"},{"key":"2021121711112148600_B62","doi-asserted-by":"publisher","first-page":"4813","DOI":"10.1073\/pnas.0909422107","article-title":"Leptin therapy in insulin-deficient type I diabetes","volume":"107","author":"Wang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021121711112148600_B63","doi-asserted-by":"publisher","first-page":"e137180","DOI":"10.1172\/jci.insight.137180","article-title":"Leptin decreases de novo lipogenesis in patients with lipodystrophy","volume":"5","author":"Baykal","year":"2020","journal-title":"JCI Insight"},{"key":"2021121711112148600_B64","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1159\/000051918","article-title":"Helicobacter pylori infection increases mucosal permeability of the stomach and intestine","volume":"63","author":"Fukuda","year":"2001","journal-title":"Digestion"},{"key":"2021121711112148600_B65","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1007\/s00535-015-1039-2","article-title":"Helicobacter pylori infection might have a potential role in hepatocyte ballooning in nonalcoholic fatty liver disease","volume":"50","author":"Sumida","year":"2015","journal-title":"J. Gastroenterol."},{"key":"2021121711112148600_B66","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12876-015-0247-9","article-title":"Helicobacter pylori infection is not associated with fatty liver disease including non-alcoholic fatty liver disease: a large-scale cross-sectional study in Japan","volume":"15","author":"Okushin","year":"2015","journal-title":"BMC Gastroenterol."},{"key":"2021121711112148600_B67","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.3748\/wjg.v22.i8.2592","article-title":"Helicobacter pylori infection is not associated with nonalcoholic fatty liver disease","volume":"22","author":"Baeg","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"2021121711112148600_B68","doi-asserted-by":"publisher","first-page":"8040262","DOI":"10.1155\/2018\/8040262","article-title":"Association between Helicobacter pylori infection and nonalcoholic fatty liver disease: a single-center clinical study","volume":"2018","author":"Cai","year":"2018","journal-title":"Gastroenterol. Res. Pract."},{"key":"2021121711112148600_B69","doi-asserted-by":"publisher","first-page":"7410801","DOI":"10.1155\/2018\/7410801","article-title":"Correlation between Helicobacter pylori infection and metabolic abnormality in general population: a cross-sectional study","volume":"2018","author":"Lu","year":"2018","journal-title":"Gastroenterol. Res. Pract."},{"key":"2021121711112148600_B70","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fmicb.2018.00073","article-title":"Helicobacter pylori infection is not associated with non-alcoholic fatty liver disease: a cross-sectional study in China","volume":"9","author":"Fan","year":"2018","journal-title":"Front. Microbiol."}],"container-title":["Bioscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/bioscirep\/article-pdf\/doi\/10.1042\/BSR20211769\/926544\/bsr-2021-1769.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/bioscirep\/article-pdf\/doi\/10.1042\/BSR20211769\/926544\/bsr-2021-1769.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T11:11:43Z","timestamp":1639739503000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/bioscirep\/article\/41\/12\/BSR20211769\/230168\/Abnormal-transaminase-and-lipid-profiles-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":70,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12,22]]}},"URL":"https:\/\/doi.org\/10.1042\/bsr20211769","relation":{},"ISSN":["0144-8463","1573-4935"],"issn-type":[{"value":"0144-8463","type":"print"},{"value":"1573-4935","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,12]]},"published":{"date-parts":[[2021,12]]},"article-number":"BSR20211769"}}